ATLANTIC AMERICAN CORP
Business
Atlantic American Corp is a holding company that operates through subsidiaries in specialty markets within the life and health and property and casualty insurance industries. It offers commercial automobile insurance, general liability, surety bonds and other P&C lines, and life and supplemental health products including ordinary life insurance, Medicare supplement and accident and health coverages. Its key operating segments are American Southern (property and casualty operations) and Bankers Fidelity (life and health operations), each managed separately. Products are distributed across state-regulated markets—American Southern is licensed in 32 states and the District of Columbia, while Bankers Fidelity sells in 46 states through commissioned independent agents, brokers and a group/employee benefits division.
Summary from filing dated 2025-03-25
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 | FY 2020 2020-12-31 |
|---|---|---|---|---|---|---|
| Insurance premiums, net | 179 | 179 | 185 | 184 | 184 | |
| Net investment income | 10 | 10 | 10 | 9 | 8 | |
| Realized investment gains, net | 1 | 70,000 | 30,000 | 5 | 7 | |
| Unrealized losses on equity securities, net | −2 | −2 | −8 | 2 | −3 | |
| Other income | 11,000 | 17,000 | 11,000 | 13,000 | 76,000 | |
| Total revenue | 188 | 187 | 188 | 200 | 195 | |
| Insurance benefits and losses incurred | 126 | 123 | 123 | 132 | 120 | |
| Commissions and underwriting expenses | 48 | 46 | 47 | 47 | 47 | |
| Interest expense | 3 | 3 | 2 | 1 | 2 | |
| Other expense | 16 | 15 | 14 | 14 | 12 | |
| Total benefits and expenses | 193 | 187 | 186 | 194 | 180 | |
| Loss before income taxes | −5 | −565,000 | 2 | 5 | 16 | |
| Income tax benefit | −996,000 | −394,000 | 571,000 | 1 | 3 | |
| Net loss | −4 | −171,000 | 2 | 4 | 12 | |
| Preferred stock dividends | −399,000 | −399,000 | −399,000 | −399,000 | −399,000 | |
| Net loss applicable to common shareholders | −5 | −570,000 | 1 | 4 | 12 | |
| Loss per common share (basic) (in dollars per share) | −0.23 | −0.03 | 0.06 | 0.19 | 0.58 | |
| Loss per common share (diluted) (in dollars per share) | −0.23 | −0.03 | 0.06 | 0.19 | 0.56 |
Consolidated Balance Sheet
| Concept | Trend | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 | FY 2020 2020-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 36 | 28 | 29 | 25 | 19 | |
| Fixed maturities, available-for-sale, at fair value (amortized cost: $236,299 and $238,626; no allowance for credit losses) | 213 | 218 | 209 | 261 | 254 | |
| Equity securities, at fair value (cost: $4,939 and $4,936) | 8 | 9 | — | — | — | |
| Other invested assets (cost: $7,946 and $6,982) | 7 | 6 | 5 | 198,000 | 3 | |
| Policy loans | 2 | 2 | 2 | 2 | 2 | |
| Real estate | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | |
| Investment in unconsolidated trusts | 1 | 1 | 1 | 1 | 1 | |
| Total investments | 230 | 237 | 229 | 283 | 279 | |
| Reinsurance (net of allowance for uncollectible reinsurance of $51 and $61) | 23 | 21 | 26 | 27 | 29 | |
| Insurance premiums and other (net of allowance for expected credit losses $201 and $217) | 27 | 24 | 15 | 15 | 28 | |
| Deferred income taxes, net | 18 | 16 | 14 | 2 | 0 | |
| Deferred acquisition costs | 45 | 44 | 42 | 39 | 40 | |
| Other assets | 12 | 9 | 9 | 9 | 8 | |
| Intangibles | 3 | 3 | 3 | 3 | 3 | |
| Total assets | 393 | 381 | 367 | 402 | 405 | |
| Future policy benefits | 98 | 92 | 86 | 87 | 91 | |
| Unearned premiums | 31 | 31 | 28 | 27 | 27 | |
| Losses and claims | 94 | 87 | 87 | 86 | 79 | |
| Other policy liabilities | 2 | 1 | 1 | 1 | 2 | |
| Total insurance reserves and policyholder funds | 225 | 212 | 203 | 202 | 199 | |
| Accounts payable and accrued expenses | 31 | 25 | 26 | 25 | 26 | |
| Revolving credit facility | 4 | 3 | 2 | 0 | — | |
| Junior subordinated debenture obligations, net | 34 | 34 | 34 | 34 | — | |
| Total liabilities | 294 | 274 | 265 | 261 | 260 | |
| Commitments and contingencies (Note 18) | — | — | — | — | — | |
| Preferred stock, $1 par, 4,000,000 shares authorized; Series D preferred, 55,000 shares issued and outstanding; $5,500 redemption value | 55,000 | 55,000 | 55,000 | 55,000 | 55,000 | |
| Common stock, $1 par, 50,000,000 shares authorized; 22,400,894 shares issued; 20,399,758 and 20,402,288 shares outstanding as of 2024 and 2023, respectively | 22 | 22 | 22 | 22 | 22 | |
| Additional paid-in capital | 57 | 57 | 57 | 57 | 57 | |
| Retained earnings | 46 | 51 | 52 | 51 | 48 | |
| Accumulated other comprehensive loss | −19 | −16 | −22 | 18 | 25 | |
| Unearned stock grant compensation | −2,000 | −13,000 | −132,000 | −73,000 | −284,000 | |
| Treasury stock, at cost, 2,001,136 and 1,998,606 shares as of 2024 and 2023, respectively | −7 | −7 | −7 | — | — | |
| Total shareholders' equity | 100 | 107 | 102 | 141 | 145 | |
| Total liabilities and shareholders' equity | 393 | 381 | 367 | 402 | 405 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 | FY 2020 2020-12-31 |
|---|---|---|---|---|---|---|
| Amortization of deferred acquisition costs | 17 | 16 | 19 | 24 | 19 | |
| Acquisition costs deferred | −18 | −18 | −23 | −23 | −20 | |
| Losses from equity method investees | 766,000 | 360,000 | −241,000 | 290,000 | — | |
| Compensation expense related to share awards | 11,000 | 119,000 | 134,000 | 211,000 | 437,000 | |
| (Benefit) provision for credit losses | −26,000 | 26,000 | 0 | — | — | |
| Depreciation and amortization | 366,000 | 652,000 | 890,000 | 1 | 980,000 | |
| Deferred income tax benefit | −2 | −3 | −2 | −1 | −2 | |
| Increase in receivables, net | −6 | −4 | 1 | 2 | 1 | |
| Increase in insurance reserves and policyholder funds | 13 | 10 | 854,000 | 3 | −3 | |
| Increase (decrease) in accounts payable and accrued expenses | 6 | −2 | — | — | — | |
| Other, net | −3 | −370,000 | −923,000 | −1 | 2 | |
| Net cash provided by operating activities | 5 | 3 | 6 | 1 | 9 | |
| Proceeds from investments sold and policy loans redeemed | 3 | 5 | 4 | 29 | 19 | |
| Proceeds from investments matured, called or redeemed | 14 | 10 | 10 | 12 | 7 | |
| Investments purchased | −14 | −18 | −17 | −35 | −27 | |
| Additions to property and equipment | −225,000 | −80,000 | −126,000 | −107,000 | −233,000 | |
| Net cash provided by (used in) investing activities | 2 | −3 | −3 | 5 | −2 | |
| Payment of dividends on Series D preferred stock | −399,000 | −399,000 | −399,000 | −399,000 | −399,000 | |
| Payment of dividends on common stock | −408,000 | −408,000 | −408,000 | −408,000 | 0 | |
| Treasury stock acquired - net employee share-based compensation | −7,000 | −12,000 | −108,000 | −153,000 | −91,000 | |
| Proceeds from revolving credit facility, net | 1 | 1 | 2 | 0 | — | |
| Net cash provided by financing activities | 186,000 | 181,000 | 1 | −954,000 | −481,000 | |
| Net increase (decrease) in cash | 7 | −562,000 | 4 | 5 | 6 | |
| Cash paid for interest | 3 | 3 | 2 | 1 | 2 | |
| Cash paid for income taxes | 580,000 | 3 | 3 | 3 | 4 |